Refine
Year of publication
Institute
- Fachbereich Elektrotechnik und Informationstechnik (1150) (remove)
Has Fulltext
- no (1150) (remove)
Document Type
- Article (629)
- Conference Proceeding (286)
- Book (112)
- Part of a Book (64)
- Patent (17)
- Report (9)
- Other (8)
- Conference: Meeting Abstract (6)
- Contribution to a Periodical (6)
- Doctoral Thesis (6)
Keywords
- Enterprise Architecture (5)
- MINLP (5)
- Engineering optimization (4)
- Digitale Transformation (3)
- Digitalisierung (3)
- Gamification (3)
- Literaturanalyse (3)
- Optimization (3)
- Powertrain (3)
- Referenzmodellierung (3)
Many biped robots deploy a form of gait that follows the zero moment point (ZMP) approach, that is, the robot is in a stable position at any point in time. This requires the robot to be fully actuated. While very stable, the draw-backs of this approach are a fairly slow gait and high energy consumption. An alternative approach is the so-called passive-dynamic walking, where the gait makes use of the inertia and dynamic stability of the robot. In this paper we describe our ongoing work of combining the principles of passive-dynamic walking on the fully-actuated biped robot Nao, which is also deployed for robotic soccer applications. We present a simple controller that allows the robot to stably rock sidewards, showing a closed limit-cycle. We discuss first results of superimposing a forward motion on the sidewards motion. Based on this we expect to endow the Nao with a fast, robust, and stable passive-dynamic walk on the fully-actuated Nao in the future.
Erfolgreiches IT-Marketing
(2013)
We have developed a double-tuned ¹H/¹⁹F birdcage resonator dedicated for hand and wrist imaging at 7 T to locally image non-steroidal anti-inflammatory drugs (NSAID) such as 2-{[3-(Trifluoromethyl) phenyl]amino}benzoic acid. The preliminary in vivo images acquired by the double-tuned ¹H/¹⁹F birdcage resonator demonstrate the feasibility for ¹H/¹⁹F hand- and wrist-imaging at 7 T. While the diagnostic quality of the coil needs to be assessed in patients with inflammatory rheumatoid disease, first ¹⁹F images of the NSAID are encouraging, and point towards the prospect of applying ¹⁹F-MRI to visualize and quantify the concentration of therapeutically-active compound at the sites of inflammation.